The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
zhong xing lu nao sun shang bing ying ji xing shang xiao hua dao chu xue fang zhi 84 li
Author(s): 
Pages: 305
Year: Issue:  3
Journal: Qianwei Journal of Medicine & Pharmacy

Abstract: 2000-01~2005-10本院收治重型颅脑损伤患者(GCS<8分)84例。男67例,女17例。年龄16~64岁,平均年龄34.4岁。其中硬膜下血肿8例、硬膜外血肿19例、脑内血肿20例、混合性血肿15例、广泛性脑挫伤22例(均经CT和/或手术证实)。将84例分为治疗组43例,对照组41例。治疗组患者伤后立即给予胃酸抑制剂洛赛克40mg,2次/d静脉注射;对照组伤后即给予H2受体阻断剂甲氰咪呱0.4g2次/d静脉注射。两组患者入院后其它预防治疗措施相同,包括积极的全身支持治疗,防治脑水肿,预防低血压、高热、酸中毒、高糖血症等可能增加颅脑损伤后应激性上消化道出血的因素,常规置胃管,每日测定胃液
Related Articles
No related articles found